HK1158623A1 - }- 合成 -雙- 三氟甲基 苯基 -乙氧基}-甲基 -苯基- -二氮雜-螺環 -癸酮化合物的中間體 - Google Patents

}- 合成 -雙- 三氟甲基 苯基 -乙氧基}-甲基 -苯基- -二氮雜-螺環 -癸酮化合物的中間體

Info

Publication number
HK1158623A1
HK1158623A1 HK11112887.811112887.8A HK11112887A HK1158623A1 HK 1158623 A1 HK1158623 A1 HK 1158623A1 HK 11112887 A HK11112887 A HK 11112887A HK 1158623 A1 HK1158623 A1 HK 1158623A1
Authority
HK
Hong Kong
Prior art keywords
phenyl
decan
diaza
spiro
intermediates
Prior art date
Application number
HK11112887.811112887.8A
Other languages
English (en)
Inventor
George G Wu
Gerald Werne
Xiaoyong Fu
Robert K Orr
Frank Xing Chen
Jian Cui
Victoria M Sprague
Fucheng Zhang
Ji Xie
Liansheng Zeng
Louis Peter Castellanos
Yuyin Chen
Marc Poirier
Ingrid Mergelsberg
Original Assignee
Opko Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opko Health Inc filed Critical Opko Health Inc
Publication of HK1158623A1 publication Critical patent/HK1158623A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/46—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Pyrrole Compounds (AREA)
HK11112887.811112887.8A 2008-09-05 2011-11-28 }- 合成 -雙- 三氟甲基 苯基 -乙氧基}-甲基 -苯基- -二氮雜-螺環 -癸酮化合物的中間體 HK1158623A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9447408P 2008-09-05 2008-09-05
PCT/US2009/056020 WO2010028232A1 (en) 2008-09-05 2009-09-04 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

Publications (1)

Publication Number Publication Date
HK1158623A1 true HK1158623A1 (zh) 2012-07-20

Family

ID=41402490

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11112887.811112887.8A HK1158623A1 (zh) 2008-09-05 2011-11-28 }- 合成 -雙- 三氟甲基 苯基 -乙氧基}-甲基 -苯基- -二氮雜-螺環 -癸酮化合物的中間體

Country Status (14)

Country Link
US (2) US9249144B2 (zh)
EP (2) EP2346823B1 (zh)
JP (2) JP5736313B2 (zh)
KR (1) KR101719004B1 (zh)
CN (2) CN102203062B (zh)
AU (1) AU2009289598B2 (zh)
CA (1) CA2736195C (zh)
ES (1) ES2552322T3 (zh)
HK (1) HK1158623A1 (zh)
HU (1) HUE026148T2 (zh)
MX (1) MX2011002475A (zh)
PL (1) PL2346823T3 (zh)
PT (1) PT2346823E (zh)
WO (1) WO2010028232A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR060353A1 (es) 2006-04-05 2008-06-11 Schering Corp Sales de hidrocloruro de 8 - [( 1- (3,5 -bis- (trifluorometil) fenil) -etoxi) -metil] -8-fenil-1,7 -diaza- spiro [4.5] decan -2-ona. composiciones farmaceuticas
MX2008012936A (es) 2006-04-05 2008-10-15 Schering Corp Formulaciones farmaceuticas: sales de 8-[{1-(3,5-bis-(trifluoromet il)fenil)-etoxi} metil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona y metodos de tratamiento usando las mismas.
AR066191A1 (es) 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
AU2009289598B2 (en) 2008-09-05 2014-09-11 Opko Health, Inc. Process and intermediates for the synthesis of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
ES2609640T3 (es) 2009-08-14 2017-04-21 Opko Health, Inc Formulaciones intravenosas de rolapitant
CN105017251B (zh) * 2015-06-30 2018-06-29 齐鲁制药有限公司 一种nk-1受体拮抗剂的制备方法及其中间体
EP3322422A1 (en) * 2015-07-15 2018-05-23 OPKO Health, Inc. Heteroaryl carbonitriles for the treatment of disease
CN106866669A (zh) * 2017-04-19 2017-06-20 成都百特万合医药科技有限公司 一种合成罗拉吡坦中间体的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620989A (en) 1992-10-28 1997-04-15 Merck Sharp & Dohme Limited 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits
CA2150951A1 (en) 1992-12-14 1994-06-23 Angus Murray Macleod 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
WO1995019344A1 (en) 1994-01-13 1995-07-20 Merck Sharp & Dohme Limited Gem-disubstituted azacyclic tachykinin antagonists
GB9626746D0 (en) 1996-12-23 1997-02-12 Knoll Ag Process
US6162805A (en) 1997-04-24 2000-12-19 Merck Sharp & Dohme Limited Use of an NK-1 receptor antagonist and an SSRI for treating obesity
DE19815275B4 (de) 1998-04-06 2009-06-25 Evonik Degussa Gmbh Alkylidenkomplexe des Rutheniums mit N-heterozyklischen Carbenliganden und deren Verwendung als hochaktive, selektive Katalysatoren für die Olefin-Metathese
US6215019B1 (en) 1998-09-01 2001-04-10 Tilliechem, Inc. Synthesis of 5-decenyl acetate and other pheromone components
KR100823365B1 (ko) 1999-05-24 2008-04-17 캘리포니아 인스티튜트 오브 테크놀로지 이미다졸리딘계 금속 카르벤 복분해 촉매
KR20020067548A (ko) 1999-12-17 2002-08-22 쉐링 코포레이션 선택적인 뉴로키닌 길항제
GB0004699D0 (en) * 2000-02-28 2000-04-19 Merck Sharp & Dohme Chemical synthesis
DE60140455D1 (de) 2000-08-10 2009-12-24 Trustees Boston College Wiederverwendbare methathese-katalysatoren
MXPA04004477A (es) * 2001-11-13 2004-08-11 Schering Corp Antagonistas del neuropeptido neuroquinina-1(nk1).
GB0129525D0 (en) 2001-12-10 2002-01-30 Floor Image Internat Ltd Improvements to floor posters
PE20030762A1 (es) * 2001-12-18 2003-09-05 Schering Corp Compuestos heterociclicos como antagonistas nk1
PL199412B1 (pl) 2002-10-15 2008-09-30 Boehringer Ingelheim Int Nowe kompleksy rutenu jako (pre)katalizatory reakcji metatezy, pochodne 2-alkoksy-5-nitrostyrenu jako związki pośrednie i sposób ich wytwarzania
ATE435226T1 (de) 2004-04-07 2009-07-15 Schering Corp Nk1-antagonisten mit kondensiertem ring
PT1799666E (pt) 2004-07-01 2016-06-17 Opko Health Inc Derivados de piperidina como antagonistas de nk1
JP4444745B2 (ja) 2004-07-08 2010-03-31 キヤノン株式会社 偏光分離素子および画像投射装置
US7354922B2 (en) * 2004-12-14 2008-04-08 Schering Corporation Bridged ring NK1 antagonists
TW200630380A (en) 2005-02-18 2006-09-01 Nat Univ Chung Hsing N-acylamino acid racemase of Deinococcus radiodurans and producing method thereof, and L-amino acid production method therefrom
US7632772B2 (en) 2005-07-04 2009-12-15 Zheng-Yun James Zhan Recyclable ruthenium catalysts for metathesis reactions
WO2007114922A2 (en) * 2006-04-05 2007-10-11 Schering Corporation Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
AR060353A1 (es) 2006-04-05 2008-06-11 Schering Corp Sales de hidrocloruro de 8 - [( 1- (3,5 -bis- (trifluorometil) fenil) -etoxi) -metil] -8-fenil-1,7 -diaza- spiro [4.5] decan -2-ona. composiciones farmaceuticas
MX2008012936A (es) 2006-04-05 2008-10-15 Schering Corp Formulaciones farmaceuticas: sales de 8-[{1-(3,5-bis-(trifluoromet il)fenil)-etoxi} metil]-8-fenil-1,7-diaza-espiro[4,5]decan-2-ona y metodos de tratamiento usando las mismas.
AR065802A1 (es) 2007-03-22 2009-07-01 Schering Corp Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
AR066191A1 (es) 2007-03-22 2009-08-05 Schering Corp Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona
AU2009289598B2 (en) 2008-09-05 2014-09-11 Opko Health, Inc. Process and intermediates for the synthesis of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl) -ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
ES2609640T3 (es) 2009-08-14 2017-04-21 Opko Health, Inc Formulaciones intravenosas de rolapitant

Also Published As

Publication number Publication date
MX2011002475A (es) 2011-08-03
EP2346823A1 (en) 2011-07-27
CN104496988A (zh) 2015-04-08
ES2552322T3 (es) 2015-11-27
EP2346823B1 (en) 2015-08-19
JP5736313B2 (ja) 2015-06-17
CA2736195A1 (en) 2010-03-11
US20160145256A1 (en) 2016-05-26
KR20110067117A (ko) 2011-06-21
CN104496988B (zh) 2017-04-12
JP2015143265A (ja) 2015-08-06
US9822116B2 (en) 2017-11-21
AU2009289598B2 (en) 2014-09-11
US20140031549A1 (en) 2014-01-30
JP2012502053A (ja) 2012-01-26
PT2346823E (pt) 2015-11-26
KR101719004B1 (ko) 2017-03-22
PL2346823T3 (pl) 2016-01-29
US9249144B2 (en) 2016-02-02
AU2009289598A1 (en) 2010-03-11
WO2010028232A1 (en) 2010-03-11
CA2736195C (en) 2017-05-16
HUE026148T2 (en) 2016-05-30
EP3034493A1 (en) 2016-06-22
CN102203062A (zh) 2011-09-28
CN102203062B (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
HK1158623A1 (zh) }- 合成 -雙- 三氟甲基 苯基 -乙氧基}-甲基 -苯基- -二氮雜-螺環 -癸酮化合物的中間體
IL213690A0 (en) Novel bicyclic heterocyclic compound
DK2202216T3 (da) Spiro-ringforbindelse samt dens anvendelse til medicinske formål
SI1904494T1 (sl) Imidazo(1,2-a)piridin spojine kot inhibitorji vegf-r2
DK2350075T3 (da) Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
IL213787A0 (en) Substituted 5,6-dihydro-6-phenylbenzo[f] isoquinolin-2-amine compounds
IL210857A0 (en) Azaindazole compounds as ccr1 receptor antagonists
HK1159113A1 (zh) 作為抗結核病藥的吡啶並嘧啶化合物
AP2010005364A0 (en) Novel heterocyclic compounds.
PL2271426T3 (pl) Zastosowanie związków hydrazydowych jako katalizatorów utleniania
HK1111995A1 (en) Substituted imidazole compounds as ksp inhibitors
HK1163063A1 (zh) 具有 受體拮抗劑活性的新型吡唑- -甲醯胺衍生物
IL210935A0 (en) Anti-malarial compounds
HK1132268A1 (en) Novel anxiolytic compounds
HK1141296A1 (zh) 橋聯六員環化合物
EP2138482A4 (en) BICYCLIC HETEROCYCLIC COMPOUND
EP2298767A4 (en) NITROGENATED BICYCLIC AND HETEROCYCLIC COMPOUND
IL195027A0 (en) Constrained compounds as cgrp-receptor antagonists
ZA200809205B (en) Constrained compounds as CGRP-receptor antagonists
IL205181A0 (en) Compounds for inhibiting ksp kinesin activity
EP2250145A4 (en) PREPARATION OF NAPHTHOCHINONE COMPOUNDS USING 2,3-DIHALONAPHOCHINONE
EP2154139A4 (en) BICYCLIC HETEROCYCLIC COMPOUND
IL211292A0 (en) Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates
IL213328A0 (en) Regeneration of 2,2'-cyclopropylidene-bis (oxazolines)
UA46479U (en) 5-AMINE-7-(4-SUBSTITUTED PHENYL)-4,7-DIHYDRO[1,2,4]TRIASOLOL-[1,5-а]PYRIMIDINE-6-CARBONITRILES POSSESSING ANTICONVULSANT ACTIVITY

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200901